Our studies have shown that variant genotypes of drug metabolizing enzymes such as cytochrome P450s (CYPs) and glutathione S‐transferases (GSTs) modify the risk to tobacco induced squamous cell carcinoma of head and neck (HNSCC) and lung. The gene discussed is HPGDS; the disease is head and neck squamous cell carcinoma.